comparemela.com

Latest Breaking News On - Aradhana sarin - Page 1 : comparemela.com

AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030

Pascal Soriot looks to set the Anglo-Swedish pharma company apart in the highly competitive cancer-medicine market.

City ofUnited kingdomPeter welfordFusion pharmaceuticals incPfizer incFusion pharmaceuticalsAradhana sarin

Svi komentari - A shocking statement from AstraZeneca; They didn t even know how to make vaccines? Media: They killed people

The chief financial officer of AstraZeneca, Aradhana Sarin, admitted during an interview that vaccines against Covid-19 are deadly.

Shutterstock stanislavsukhinAradhana sarin

AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript

AZN earnings call for the period ending December 31, 2023.

United statesUnited kingdomCity ofJames gordonMark purcellJames gordon jpmorganPeter welfordMark purcell morgan stanleySimon baker redburnLuisa hector berenbergMatthew westonSandy barnettSundal collierAndrew baumRedburn atlanticTim anderson

AstraZeneca Partners With AI Company to Find Cure For Cancer

Absci, a drug and target discovery company, has been harnessing the power of deep learning AI to develop new and existing disease treatments.

Milton keynesUnited kingdomUnited statesSean mcclainDepartment of healthRice universityAi life sciences accelerator missionDepartment of scienceAradhana sarinSocial careSciences accelerator missionMinister rishi sunakBletchley parkBletchley declarationArtificial intelligenceCovid 19

AstraZeneca plays up China, downplays patent loss in latest earnings: CFO

AstraZeneca (AZN) reported strong earnings Friday, including $22 billion, or 4% revenue growth, in the first half of the year, and kept its 2023 forecast stable.

United statesUs chamberUs health departmentInflation reduction actRevenue growthAradhana sarinDouble digit revenue growthPharmaceutical companies

vimarsana © 2020. All Rights Reserved.